ONCT logo

Oncternal Therapeutics (ONCT) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$6.70 M
-$30.45 M-81.97%

December 31, 2023


Summary


Performance

ONCT Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherONCTbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$13.08 M
+$6.70 M+104.94%

September 30, 2024


Summary


Performance

ONCT Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherONCTbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

ONCT Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-82.0%+104.5%
3 y3 years-94.3%+16.3%
5 y5 years-76.3%+16.3%

ONCT Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-92.6%at low-85.6%+104.9%
5 y5-year-94.3%at low-88.8%+104.9%
alltimeall time-94.4%+334.3%-89.8%+153.7%

Oncternal Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$13.08 M(+104.9%)
Jun 2024
-
$6.38 M(-0.2%)
Mar 2024
-
$6.40 M(-4.5%)
Dec 2023
$6.70 M(-82.0%)
$6.70 M(-55.1%)
Sep 2023
-
$14.93 M(-5.7%)
Jun 2023
-
$15.83 M(+40.8%)
Mar 2023
-
$11.24 M(-69.7%)
Dec 2022
$37.14 M(-59.1%)
$37.14 M(-47.4%)
Sep 2022
-
$70.63 M(-10.5%)
Jun 2022
-
$78.90 M(-4.0%)
Mar 2022
-
$82.16 M(-9.5%)
Dec 2021
$90.77 M(-22.2%)
$90.77 M(-6.8%)
Sep 2021
-
$97.38 M(-6.1%)
Jun 2021
-
$103.66 M(-6.8%)
Mar 2021
-
$111.21 M(-4.7%)
Dec 2020
$116.74 M(+482.2%)
$116.74 M(+449.1%)
Sep 2020
-
$21.26 M(+27.9%)
Jun 2020
-
$16.62 M(+3.7%)
Mar 2020
-
$16.02 M(-20.1%)
Dec 2019
$20.05 M(-29.0%)
$20.05 M(-13.2%)
Sep 2019
-
$23.10 M(-19.0%)
Jun 2019
-
$28.52 M(+35.7%)
Mar 2019
-
$21.01 M(-25.6%)
Dec 2018
$28.26 M(+78.7%)
$28.26 M(+22.4%)
Sep 2018
-
$23.09 M(+39.8%)
Jun 2018
-
$16.51 M(+10.4%)
Mar 2018
-
$14.96 M(-5.4%)
Dec 2017
$15.82 M(+77.5%)
$15.82 M(-70.4%)
Sep 2017
-
$53.43 M(+936.3%)
Jun 2017
-
$5.16 M(-33.7%)
Mar 2017
-
$7.77 M(-12.8%)
Dec 2016
$8.91 M(-36.6%)
$8.91 M(+8.2%)
Sep 2016
-
$8.24 M(-13.9%)
Jun 2016
-
$9.57 M(-20.6%)
Mar 2016
-
$12.06 M(-14.2%)
Dec 2015
$14.06 M(-21.4%)
$14.06 M(+19.1%)
Sep 2015
-
$11.80 M(-17.6%)
Jun 2015
-
$14.32 M(+1.1%)
Mar 2015
-
$14.16 M(-20.8%)
Dec 2014
$17.88 M(+23.1%)
$17.88 M(+85.7%)
Sep 2014
-
$9.63 M(-13.9%)
Jun 2014
-
$11.18 M(-50.2%)
Mar 2014
-
$22.43 M(+54.4%)
Dec 2013
$14.53 M
$14.53 M(-24.7%)
DateAnnualQuarterly
Sep 2013
-
$19.28 M(-31.7%)
Jun 2013
-
$28.25 M(-21.8%)
Mar 2013
-
$36.14 M(-24.8%)
Dec 2012
$48.04 M(-24.6%)
$48.04 M(+24.0%)
Sep 2012
-
$38.73 M(-18.1%)
Jun 2012
-
$47.32 M(-15.4%)
Mar 2012
-
$55.91 M(-12.3%)
Dec 2011
$63.74 M(+9.6%)
$63.74 M(-13.0%)
Sep 2011
-
$73.30 M(-11.1%)
Jun 2011
-
$82.42 M(+92.6%)
Mar 2011
-
$42.79 M(-26.5%)
Dec 2010
$58.18 M(+44.7%)
$58.18 M(+231.5%)
Sep 2010
-
$17.55 M(-12.2%)
Jun 2010
-
$19.99 M(-32.4%)
Mar 2010
-
$29.58 M(-26.5%)
Dec 2009
$40.22 M(-57.9%)
$40.22 M(-15.3%)
Sep 2009
-
$47.46 M(-29.7%)
Jun 2009
-
$67.50 M(-15.8%)
Mar 2009
-
$80.17 M(-16.1%)
Dec 2008
$95.51 M(-4.7%)
$95.51 M(-6.2%)
Sep 2008
-
$101.78 M(-9.9%)
Jun 2008
-
$112.94 M(-12.0%)
Mar 2008
-
$128.31 M(+28.1%)
Dec 2007
$100.18 M(-16.2%)
$100.18 M(+10.2%)
Sep 2007
-
$90.94 M(-10.9%)
Jun 2007
-
$102.03 M(-8.4%)
Mar 2007
-
$111.43 M(-6.8%)
Dec 2006
$119.55 M(+61.5%)
$119.55 M(+168.3%)
Sep 2006
-
$44.55 M(-19.8%)
Jun 2006
-
$55.56 M(-14.9%)
Mar 2006
-
$65.28 M(-11.8%)
Dec 2005
$74.01 M(+14.7%)
$74.01 M(+95.8%)
Sep 2005
-
$37.81 M(-21.4%)
Jun 2005
-
$48.08 M(-13.5%)
Mar 2005
-
$55.58 M(-13.9%)
Dec 2004
$64.53 M(+336.9%)
$64.53 M(-15.2%)
Sep 2004
-
$76.09 M(-6.6%)
Jun 2004
-
$81.44 M(+1.0%)
Mar 2004
-
$80.62 M(+445.9%)
Dec 2003
$14.77 M(+65.5%)
$14.77 M
Dec 2002
$8.93 M(+1.0%)
-
Dec 2001
$8.83 M(+231.2%)
-
Dec 2000
$2.67 M(+73.0%)
-
Dec 1999
$1.54 M
-

FAQ

  • What is Oncternal Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Oncternal Therapeutics?
  • What is Oncternal Therapeutics annual cash & cash equivalents year-on-year change?
  • What is Oncternal Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Oncternal Therapeutics?
  • What is Oncternal Therapeutics quarterly cash and cash equivalents year-on-year change?

What is Oncternal Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of ONCT is $6.70 M

What is the all time high annual cash & cash equivalents for Oncternal Therapeutics?

Oncternal Therapeutics all-time high annual cash & cash equivalents is $119.55 M

What is Oncternal Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, ONCT annual cash & cash equivalents has changed by -$30.45 M (-81.97%)

What is Oncternal Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of ONCT is $13.08 M

What is the all time high quarterly cash and cash equivalents for Oncternal Therapeutics?

Oncternal Therapeutics all-time high quarterly cash and cash equivalents is $128.31 M

What is Oncternal Therapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, ONCT quarterly cash and cash equivalents has changed by +$6.68 M (+104.49%)